ReviewJournal of virology2026
Nairobi sheep disease virus: an emerging threat with unresolved pathogenesis and zoonotic potential.
Review in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Phylogeography and evolutionary dynamics of Nairobi sheep disease virus.Virus evolution · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Nairobi sheep disease virus (NSDV), a tick-borne orthonairovirus, causes severe hemorrhagic disease in small ruminants with mortality rates reaching 90% in naïve populations. Its recent emergence in China, the world's largest small ruminant producer, marks a significant eastward expansion and poses immediate threats to global food security and animal health. This escalating crisis, however, stands in stark contrast to critical gaps in understanding the virus's molecular pathogenesis. The mechanisms governing cellular entry, innate immune evasion, and induction of lethal vascular pathology remain poorly characterized, severely hampering countermeasure development. This review synthesizes the current epidemiological landscape of NSDV and delineates key knowledge gaps in its molecular biology. We place particular emphasis on the unexplored viral life cycle and the host response and conclude by proposing a prioritized research agenda aimed at bridging these mechanistic gaps. Within a One Health framework, such efforts are essential to mitigate the veterinary, economic, and potential zoonotic impacts of this emerging arthropod-borne threat.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.